Company Filing History:

6 out of 4,455

Pfizer Corporation

where one patent can have more than one assignee

Years Active: 1999-2007

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7297682 - Diphosphate salt of a 4″—substituted-9-deoxo-9 A—AZA—homoerythromycin derivatives and its pharmaceutical composition (2007-11-20),

2. 6861412 - Diphosphate salt of A 4″-substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition (2005-03-01),

3. 6583274 - Crystalline forms of macrolide antibiotic (2003-06-24),

4. 6465437 - Diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-9A- homoerythromycin derivative and its pharmaceutical composition (2002-10-15),

5. 6329345 - 13-membered azalides and their use as antibiotic agents (2001-12-11),

6. 6100240 - Macrolide derivatives (2000-08-08),

7. 6007848 - Use of 1,4-anhydroglucitol/galactitol in low calorie food products, and (1999-12-28),

Title: The Innovations of Robert J Rafka

Introduction

Robert J Rafka is a notable inventor based in Stonington, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibacterial and antiprotozoal agents. With a total of 7 patents to his name, Rafka's work has had a considerable impact on medical treatments.

Latest Patents

Rafka's latest patents include a diphosphate salt of a 4″-substituted-9-deoxo-9A-AZA-homoerythromycin derivative and its pharmaceutical composition. This invention relates to a novel crystalline diphosphate salt that is useful as an antibacterial and antiprotozoal agent in mammals. The invention also encompasses pharmaceutical compositions containing the free base of the diphosphate salt and methods for treating bacterial and protozoal infections in mammals. The free base of the diphosphate salt possesses potent activity against various infections when administered parenterally.

Career Highlights

Throughout his career, Robert J Rafka has worked with prominent companies such as Pfizer Corporation and Cultor Corporation. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Rafka has collaborated with notable colleagues, including Colman B Ragan and Douglas J M Allen. These partnerships have further enhanced his contributions to the field of pharmaceuticals.

Conclusion

Robert J Rafka's innovative work in the pharmaceutical industry has led to significant advancements in the treatment of bacterial and protozoal infections. His contributions continue to influence medical practices and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.